JBS N.V. JBS
11.57
0.21
1.85%
as of 25 Sep
- Market cap
- $12.2B
- P/E
- 11.3×
Follow JBS
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
11.62 | 11.23 | 7.55 | 6.78 |
+5 more quarters Free account |
P/S ratio |
0.13 | 0.22 | 0.18 | 0.20 | |
P/FCF ratio |
22.09 | 52.45 | 17.14 | 20.26 | |
P/Operating CF |
14.20 | (24.37) | 7.96 | 15.93 | |
P/B ratio |
1.34 | 2.12 | 1.62 | 1.74 | |
Price to Tangible BV |
9.38 | 14.94 | 8.35 | 9.40 | |
EV/Sales |
0.36 | 0.44 | 0.39 | 0.42 | |
EV/EBITDA |
5.69 | 6.27 | 5.13 | 4.96 | |
EV/Operating CF |
10.71 | 14.30 | 11.32 | 13.66 | |
EV/FCF |
59.41 | 105.16 | 36.92 | 42.40 | |
Quick Ratio |
0.72 | 0.71 | 0.86 | 0.78 | |
Current Ratio |
1.53 | 1.50 | 1.60 | 1.60 | |
Net Debt/EBITDA |
16.53 | 17.54 | 11.28 | 10.04 | |
Debt/Assets |
52.52% | 50.42% | 49.83% | 50.26% | |
Debt/Equity |
2.66 | 2.51 | 2.36 | 2.34 | |
Asset Turnover |
2.08 | 3.91 | 3.82 | 3.76 | |
Operating CF/Net income |
(8.34) | (3.58) | 4.66 | 1.79 | |
Capex/Depreciation |
(0.93) | (0.88) | (1.32) | (0.90) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
8.36% | 8.60% | 8.38% | 7.83% | |
Intangible Assets out of Total Assets |
0.17 | 0.17 | 0.17 | 0.18 | |
Share Based Compensation of Revenue |
0.08% | 0.03% | 0.04% | 0.03% | |
Graham Net Nets |
(1.57) | (0.96) | (1.12) | (1.03) | |
Graham Number |
14.27 | 17.45 | 19.57 | 20.61 | |
Earnings Yield |
8.61% | 8.91% | 13.24% | 14.75% | |
Free Cash Flow Yield |
4.53% | 1.91% | 5.83% | 4.94% | |
Revenue per Share |
23.41 | 20.18 | 21.58 | 20.37 | |
Operating CF per Share |
0.83 | (0.74) | 1.81 | 0.94 | |
Capex per Share |
(0.58) | (0.51) | (0.77) | (0.48) | |
Free Cash Flow per Share |
0.25 | (1.24) | 1.04 | 0.46 | |
Cash per Share |
3.56 | 3.23 | 4.42 | 3.71 | |
Shareholders Equity per Share |
8.87 | 8.46 | 8.91 | 8.57 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
8.87 | 8.46 | 8.91 | 8.57 | |
Free Cash Flow |
256.84 | (1,332.06) | 1,111.20 | 511.76 | |
Working Capital |
6,174.15 | 5,896.97 | 6,896.39 | 6,638.33 | |
Capital Expenditures |
(595.22) | (542.77) | (824.39) | (527.75) | |
Net Current Asset Value |
(19,022.55) | (18,502.09) | (17,195.50) | (17,005.26) | |
EV/EBIT |
10.00 | 10.25 | 7.98 | 7.28 | |
Capex to Sales |
0.02 | 0.03 | 0.04 | 0.02 | |
Net Profit Margin |
(0.43%) | 1.02% | 1.80% | 2.57% | |
Price to Operating Income |
3.72 | 5.11 | 3.70 | 3.48 | |
| Other line items | |||||
Average Receivables |
4,475.26 | 4,624.42 | — | — | |
Average Payables |
5,434.94 | 5,459.42 | — | — | |
Average Inventory |
8,464.28 | 7,629.98 | — | — | |
Average Assets |
43,827.44 | 22,590.15 | 22,578.24 | 22,093.06 | |
Average Common Equity |
9,152.73 | 8,597.53 | — | — |
Columns are period end dates